Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chondrocytes | 10 | 2016 | 16 | 1.370 |
Why?
|
| SOX9 Transcription Factor | 6 | 2016 | 7 | 1.120 |
Why?
|
| Protein Kinase C | 13 | 2003 | 16 | 0.770 |
Why?
|
| Mitogen-Activated Protein Kinases | 13 | 2003 | 13 | 0.750 |
Why?
|
| Cell Differentiation | 8 | 2016 | 31 | 0.570 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 26 | 0.560 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2014 | 7 | 0.520 |
Why?
|
| Signal Transduction | 11 | 2009 | 73 | 0.500 |
Why?
|
| Collagen Type II | 4 | 2016 | 4 | 0.490 |
Why?
|
| Animals | 19 | 2016 | 748 | 0.490 |
Why?
|
| Chondrogenesis | 5 | 2003 | 10 | 0.450 |
Why?
|
| Isoenzymes | 8 | 2002 | 11 | 0.410 |
Why?
|
| Mesoderm | 8 | 2003 | 8 | 0.400 |
Why?
|
| Apoptosis | 5 | 2003 | 24 | 0.370 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 6 | 2000 | 10 | 0.350 |
Why?
|
| Genome | 1 | 2010 | 1 | 0.330 |
Why?
|
| Cartilage, Articular | 3 | 2003 | 32 | 0.290 |
Why?
|
| Cartilage | 6 | 2010 | 12 | 0.270 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 7 | 2003 | 7 | 0.270 |
Why?
|
| Mice | 6 | 2016 | 215 | 0.230 |
Why?
|
| Cells, Cultured | 9 | 2016 | 88 | 0.220 |
Why?
|
| Nitric Oxide | 5 | 2003 | 10 | 0.220 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 11 | 2003 | 11 | 0.220 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2003 | 10 | 0.200 |
Why?
|
| Enzyme Activation | 9 | 2003 | 17 | 0.200 |
Why?
|
| Macrophages | 2 | 1999 | 8 | 0.190 |
Why?
|
| Binding Sites | 2 | 2014 | 12 | 0.190 |
Why?
|
| Gene Expression Profiling | 2 | 2014 | 11 | 0.190 |
Why?
|
| Chick Embryo | 8 | 2003 | 9 | 0.190 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 8 | 2003 | 12 | 0.190 |
Why?
|
| Caspases | 5 | 2003 | 11 | 0.180 |
Why?
|
| Immunosuppressive Agents | 1 | 2001 | 4 | 0.180 |
Why?
|
| Sirolimus | 1 | 2001 | 3 | 0.180 |
Why?
|
| Receptors, Vitronectin | 1 | 2000 | 3 | 0.160 |
Why?
|
| Receptors, Laminin | 1 | 1999 | 1 | 0.160 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2016 | 3 | 0.150 |
Why?
|
| Enzyme Inhibitors | 7 | 2003 | 26 | 0.130 |
Why?
|
| Introns | 1 | 2016 | 5 | 0.130 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2016 | 1 | 0.130 |
Why?
|
| Osteoblasts | 1 | 2016 | 12 | 0.130 |
Why?
|
| Osteogenesis | 1 | 2016 | 37 | 0.120 |
Why?
|
| Protein Binding | 2 | 2014 | 21 | 0.120 |
Why?
|
| Humans | 5 | 2016 | 1907 | 0.120 |
Why?
|
| Cadherins | 4 | 2003 | 4 | 0.110 |
Why?
|
| Cell Line | 3 | 2010 | 43 | 0.110 |
Why?
|
| Position-Specific Scoring Matrices | 1 | 2014 | 1 | 0.110 |
Why?
|
| Nucleotide Motifs | 1 | 2014 | 1 | 0.110 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2014 | 2 | 0.110 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 3 | 0.110 |
Why?
|
| Protein Transport | 1 | 2014 | 4 | 0.110 |
Why?
|
| Gene Expression | 1 | 2014 | 27 | 0.110 |
Why?
|
| Mice, Knockout | 1 | 2014 | 40 | 0.110 |
Why?
|
| Rats | 2 | 2016 | 159 | 0.110 |
Why?
|
| Trans-Activators | 3 | 2003 | 3 | 0.110 |
Why?
|
| Down-Regulation | 4 | 2016 | 19 | 0.100 |
Why?
|
| Blotting, Western | 3 | 2003 | 19 | 0.100 |
Why?
|
| Cell Division | 3 | 2001 | 9 | 0.100 |
Why?
|
| Caspase 3 | 5 | 2003 | 5 | 0.090 |
Why?
|
| Fibronectins | 3 | 2000 | 4 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2003 | 60 | 0.090 |
Why?
|
| Cell Adhesion | 3 | 2000 | 8 | 0.090 |
Why?
|
| Protein Kinase C-alpha | 5 | 2002 | 5 | 0.090 |
Why?
|
| Limb Buds | 2 | 2009 | 2 | 0.090 |
Why?
|
| Rabbits | 4 | 2003 | 52 | 0.090 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2010 | 1 | 0.080 |
Why?
|
| Transcriptional Activation | 1 | 2010 | 4 | 0.080 |
Why?
|
| Gene Regulatory Networks | 1 | 2010 | 3 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 6 | 0.080 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2000 | 15 | 0.080 |
Why?
|
| Integrins | 2 | 2000 | 4 | 0.080 |
Why?
|
| Body Patterning | 1 | 2009 | 1 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2009 | 9 | 0.080 |
Why?
|
| Cytoskeletal Proteins | 3 | 2003 | 3 | 0.070 |
Why?
|
| Bone and Bones | 1 | 2009 | 52 | 0.070 |
Why?
|
| Phosphorylation | 3 | 2001 | 23 | 0.070 |
Why?
|
| Collagen | 3 | 2003 | 22 | 0.060 |
Why?
|
| Flavonoids | 5 | 2003 | 5 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2003 | 2 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2003 | 3 | 0.050 |
Why?
|
| Tretinoin | 1 | 2003 | 2 | 0.050 |
Why?
|
| NF-kappa B | 1 | 2003 | 5 | 0.050 |
Why?
|
| Time Factors | 2 | 2001 | 143 | 0.050 |
Why?
|
| Cell Adhesion Molecules | 2 | 2000 | 2 | 0.050 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1999 | 4 | 0.050 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2001 | 1 | 0.050 |
Why?
|
| Cell Culture Techniques | 1 | 2001 | 4 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2001 | 18 | 0.050 |
Why?
|
| Carbazoles | 1 | 2000 | 2 | 0.040 |
Why?
|
| Sulfonamides | 1 | 2000 | 9 | 0.040 |
Why?
|
| Epidermal Growth Factor | 1 | 2000 | 1 | 0.040 |
Why?
|
| Cell Fractionation | 1 | 2000 | 2 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2000 | 18 | 0.040 |
Why?
|
| Integrin alpha6beta1 | 1 | 1999 | 1 | 0.040 |
Why?
|
| Protein Kinase C-delta | 1 | 1999 | 1 | 0.040 |
Why?
|
| Laminin | 1 | 1999 | 2 | 0.040 |
Why?
|
| Receptors, Muscarinic | 1 | 1999 | 1 | 0.040 |
Why?
|
| beta Catenin | 3 | 2003 | 7 | 0.040 |
Why?
|
| Nitroprusside | 3 | 2002 | 4 | 0.030 |
Why?
|
| SOXD Transcription Factors | 1 | 2016 | 1 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 8 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 16 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2016 | 19 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2009 | 7 | 0.030 |
Why?
|
| alpha Catenin | 2 | 2003 | 2 | 0.020 |
Why?
|
| Phenotype | 2 | 2002 | 52 | 0.020 |
Why?
|
| Nitric Oxide Donors | 2 | 2002 | 2 | 0.020 |
Why?
|
| Caspase Inhibitors | 2 | 2001 | 2 | 0.020 |
Why?
|
| Dimerization | 1 | 2010 | 2 | 0.020 |
Why?
|
| Chromatin | 1 | 2010 | 3 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 5 | 0.020 |
Why?
|
| DNA | 1 | 2010 | 21 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 34 | 0.020 |
Why?
|
| Mutation | 1 | 2010 | 64 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 1999 | 2 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2009 | 25 | 0.020 |
Why?
|
| Cytochalasin D | 1 | 2003 | 2 | 0.010 |
Why?
|
| Proteoglycans | 1 | 2003 | 11 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2002 | 2 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2002 | 4 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2002 | 4 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2002 | 2 | 0.010 |
Why?
|
| DNA Primers | 1 | 2002 | 9 | 0.010 |
Why?
|
| Base Sequence | 1 | 2002 | 17 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2002 | 19 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2001 | 2 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2001 | 2 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2001 | 13 | 0.010 |
Why?
|
| Pyridines | 1 | 2001 | 9 | 0.010 |
Why?
|
| Imidazoles | 1 | 2001 | 12 | 0.010 |
Why?
|
| Models, Biological | 1 | 2001 | 99 | 0.010 |
Why?
|
| Embryonic Induction | 1 | 2000 | 1 | 0.010 |
Why?
|
| Receptors, Fibronectin | 1 | 2000 | 1 | 0.010 |
Why?
|
| Isoquinolines | 1 | 2000 | 4 | 0.010 |
Why?
|
| Pyrroles | 1 | 2000 | 2 | 0.010 |
Why?
|
| Indoles | 1 | 2000 | 7 | 0.010 |
Why?
|
| Mitogens | 1 | 1999 | 1 | 0.010 |
Why?
|
| HL-60 Cells | 1 | 1999 | 1 | 0.010 |
Why?
|
| Bucladesine | 1 | 1999 | 2 | 0.010 |
Why?
|
| Carbachol | 1 | 1999 | 1 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 1999 | 1 | 0.010 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 1999 | 1 | 0.010 |
Why?
|
| Protein Kinase C-epsilon | 1 | 1999 | 1 | 0.010 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 1999 | 2 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1999 | 16 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1998 | 1 | 0.010 |
Why?
|